Dose escalation study of bovine lactoferrin in preterm infants: getting the dose right
Authors:
- 1 February 2021
- journal article
- research article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 99 (1) , 7-13
Abstract
Lactoferrin as a nutritional enteral supplement has emerged as a novel preventative therapy against serious infections in preterm infants, although neonatal studies have demonstrated variable results, in part due to the lack of pharmacokinetic data and differences in the products tested. We conducted a prospective, dose escalation (100, 200, and 300 mg·kg–1·day–1) safety study of bovine lactoferrin (Glanbia Nutritionals, USA) dissolved in sterile water (100 mg·mL–1) for 30 days in preterm infants with birth weight –1·day–1, respectively)] over a 10-month period. No AEs related to the study solution occurred, and lactoferrin was tolerated by each group. During lactoferrin supplementation, one bloodstream infection occurred in each group, but there were no incidences of urinary tract infections and no cases of necrotizing enterocolitis. Postnatal cytomegalovirus acquisition was detected in the group treated with 200 mg·kg–1·day–1 (n = 2). There were no adverse effects on hepatic, renal, or hematologic function. All of the patients survived to discharge. Bovine lactoferrin at doses up to 300 mg·kg–1·day–1 is safe in preterm infants. Future studies examining higher doses of lactoferrin, length of treatment, and potency of different products will aid in determining the optimal approach for the use of lactoferrin to prevent infections in preterm infants.Keywords
This publication has 32 references indexed in Scilit:
- Neonatal Acute Kidney InjuryPediatrics, 2015
- Lactoferrin Promotes Early Neurodevelopment and Cognition in Postnatal Piglets by Upregulating the BDNF Signaling Pathway and PolysialylationMolecular Neurobiology, 2014
- Protective effects of maternal nutritional supplementation with lactoferrin on growth and brain metabolismPediatric Research, 2013
- Ultraviolet-C Irradiation: A Novel Pasteurization Method for Donor Human MilkPLOS ONE, 2013
- Protective Proteins in Mammalian MilksNeoReviews, 2012
- Saliva Polymerase-Chain-Reaction Assay for Cytomegalovirus Screening in NewbornsNew England Journal of Medicine, 2011
- Lactoferrin Supplementation to Prevent Nosocomial Infections in Preterm InfantsJAMA, 2009
- Bovine Lactoferrin Supplementation for Prevention of Late-Onset Sepsis in Very Low-Birth-Weight NeonatesA Randomized TrialJAMA, 2009
- The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infantsEarly Human Development, 2007
- Lactoferrin Induces Concentration-Dependent Functional Modulation of Intestinal Proliferation and DifferentiationPediatric Research, 2007